Digital pathology
Paige
Digital pathology AI applications for cancer pathology, including Paige Prostate.
Last updated: June 5, 2026
Back to directoryPathAI medical AI product profile
AI-enabled digital pathology platform with image management and algorithm access.
Digital pathology
Best fit
Labs that need an image management system with AI application access and pathology workflow support.
- Primary use case
- Digital pathology image management, AI algorithms, quality control, and lab workflow
- Audience
- Anatomic pathology labs, reference labs, health systems, and biopharma
- Risk level
- High
- Pricing signal
- Enterprise pricing; request current terms.
- Official sources
- 4 official sources
Compare within workflow: Digital pathology · comparison shortlist · source index
Regulatory, privacy, evidence, and workflow lens
Product-specific review. These product-specific signals summarize what the cited sources imply before treating PathAI as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Distinguish AISight image-management, AISight Dx, partner algorithms, and research-only AI tools before treating any workflow as diagnostic. |
|---|---|
| Privacy | Review slide storage, cloud hosting, LIS integration, user roles, audit logs, retention, and customer data-use terms for lab operations. |
| Evidence | Validate scanner compatibility, image quality, algorithm performance, pathologist review burden, and lab population fit before routine diagnostic use. |
| Workflow | Best evaluated as a digital-pathology platform with AI access, requiring lab validation, pathologist signout controls, and clear separation of RUO and diagnostic tools. |
Where PathAI fits
PathAI says AISight powers digital pathology workflows and AI applications; AISight Dx materials describe FDA-cleared primary-diagnosis image management with specified scanner support, while other AI algorithms and research workflows require separate intended-use review.
Not for: Diagnostic use of research-only algorithms or unvalidated lab workflows.
What to verify before using PathAI
- Which AISight version and algorithms are diagnostic versus research use only.
- Scanner, LIS, and storage integration.
- Security and privacy controls.
- Pathologist oversight and lab validation requirements.
Source links
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.
- www.pathai.com / aisight
- www.pathai.com / aisightdx-digital-pathology-solution
- www.pathai.com / news / pathai-receives-fda-clearance-for-aisight-dx-platform-for-primary-diagnosis
- www.accessdata.fda.gov / cdrh_docs / reviews
Related medical AI products
Digital pathology
Hologic Genius Digital Diagnostics
FDA-cleared digital cytology system combining volumetric imaging, Genius Cervical AI, image management, and cytologist or pathologist review.
Digital pathology
Ibex Medical Analytics
Clinical-grade AI pathology platform for cancer diagnostics and pathology workflow support.
Digital pathology
Deep Bio DeepDx Prostate
CE-marked and Korea MFDS-approved prostate pathology AI that analyzes digitized H&E slides for cancer detection and Gleason-pattern support under pathologist review.